Mass General Cancer Center Grand Rounds
Grand Rounds
Mass General Cancer Center Grand Rounds is a CME accredited weekly seminar series. Cutting edge topics, case studies and conference highlights will be presented.
Fall 2024 - Spring 2025 Grand Rounds
Time: Thursdays, 12:00 PM–1:00 PM
Course Director: Colin D. Weekes, MD, PhD
Co-Course Directors: Douglas Micalizzi, MD, PhD; Lecia Sequist, MD, MPH
The Mass General Cancer Center Grand Rounds program has emerged as a premiere oncology conference in Boston. This program provides an opportunity for Mass General professional staff and fellows to learn from national and international leaders and innovators in cancer treatment and research. This year’s theme for the series is Early Detection.
Grand Rounds offers CME credit, and is structured as a 45-minute lecture followed by 15 minutes of discussion and interaction. Please see below to view the weekly topics and presenters.
Outside of Mass General and interested in viewing the Grand Rounds? Click here to access our new Mass General Cancer Center Grand Rounds subscription available to the public.
Fall 2024 Grand Rounds Schedule
September 19, 2024
Why Should Cancer Centers Develop a Focus on Early Detection?
Moderator:
Lecia Sequist, MD, MPH
Mass General Cancer Center
Panelists:
David P. Ryan, MD
Mass General Cancer Center
Douglas Micalizzi, MD, PhD
Mass General Cancer Center
Erica Warner, ScD
Mass General Research Institute
Elsie M. Taveras, MD, MPH
Mass General Brigham
September 26, 2024
Infectious Disease MGH, A Global View on Virally-Mediated Cancer Risk, Cervical Cancer
Ruanne Barnabas, MBChB, MSc, DPhil
Massachusetts General Hospital
October 10, 2024
"How I Live" Documentary Session
Irini Ablanti, DrPH, MPH, MA
Harvard Humanitarian Initiative
Harvard T. H. Chan School of Public Health
Harvard Medical School
October 17, 2024
Clinical Pathologic Conference: A 75-Year-Old Woman with Multiple Myeloma and Altered Mental Status
Jorg Dietrich, MD, PhD
Mass General Cancer Center
Paul G. Richardson, MD
Dana-Farber Cancer Institute
Matthew Frigault, MD
Mass General Cancer Center
Otto Rapalino, MD
Massachusetts General Hospital
Maria Martinez-Lage Alvarez, MD
Massachusetts General Hospital
October 24, 2024
Town Hall: Health Care in 2024
Congressman Jake Auchincloss
Massachusetts 4th District
October 31, 2024
The Grand Challenge of Cancer Disparities
Melissa Davis, PhD
Morehouse School of Medicine
November 7, 2024
Space-Based Research: Predicting and Preventing Accelerated Stem Cell Aging & Cancer Evolution
Catriona Jamieson, MD, PhD
University of California San Diego
November 14, 2024
Multi-Cancer Detection Assays: Hope or Hype?
Moderator:
Lecia Sequist, MD, MPH
Mass General Cancer Center
Panelists:
Tomasz Beer, MD
Exact Sciences
Jennifer Haas, MD
Massachusetts General Hospital
Betsy O’Donnell, MD
Dana-Farber Cancer Institute
November 21, 2024
Cancer Early Detection Hype or Hope? Lessons from the Oesophagus and Beyond
Rebecca Fitzgerald, OBE, MACantab, MD, FMedSci, EMBO
University of Cambridge
December 5, 2024
Early detection of high grade serous endometrial and ovarian cancers. One step ahead.
Lucy Gilbert, MD, MSc, FRCOG
McGill University
December 12, 2024
Title TBA
Ash Alizadeh, MD, PhD
Stanford Medicine
December 19, 2024
Lung Cancer Screening as an Opportunity for Community Outreach and Engagement
Moderator:
Efren Flores, MD
Massachusetts General Hospital
Panelists:
Chi-Fu Jeffrey Yang, MD
Massachusetts General Hospital
Rian Hasson, MD, MPH, FACS
Brigham and Women’s Hospital
Michael Gieske, MD
St. Elizabeth Healthcare
Spring 2025 Grand Rounds Schedule TBA
Previous Grand Rounds
Spring 2024
January 4, 2024
ASH Update
Classical Heme (Jonathan Carlson, MD, PhD)
Leukemia (Rupa Narayan, MD)
Lymphoma (Jacob Soumerai, MD)
Myeloma (Diana Cirstea, MD)
BMT (Richard Newcomb, MD)
Cell Therapy (Mark Leick, MD)
January 11, 2024
Integrating Clinical and Laboratory Research to Identify Mechanisms of Response and Resistance to Immune Checkpoint Therapy
Padmanee Sharma, MD, PhD
MD Anderson Cancer Center
January 18, 2024
From the Ether Dome to Seldin Plaza: My Path in Renal Cell Carcinoma
Tian Zhang, MD
UT Southwestern Medical Center
January 25, 2024
Can’t Stop, Won’t Stop: The Development of New Therapies, and New Trialists, Toward a Future of Cure
Janice Mehnert, MD
NYU Langone Health
February 1, 2024
From Trailblazers to Leaders: Role of Women As Division Chiefs
S. Gail Eckhardt, MD, FASCO
Baylor College of Medicine
Merry Markham, MD, FACP, FASCP
University of Florida Health
February 8, 2024
Advocacy in Oncology: Connecting What Matters with Our Science and Care
Pamela Kunz, MD
Yale School of Medicine
February 29, 2024
Brain Metastases of Breast Cancer
Patricia Steeg, PhD
National Institutes of Health
March 7, 2024
Gastric Cancer Program: Innovations and Advances
Vivian Strong, MD, FACS
Memorial Sloan Kettering Cancer Center
March 14, 2024
Rethinking Radiation Oncology Using HPV Driven Oropharyngeal Carcinoma as a Model
Nancy Lee, MD, FASTRO
Memorial Sloan Kettering Cancer Center
March 21, 2024
Bridging the GAP While Shattering Ceilings
Rachna Shroff, MD, MS, FASCO
University of Arizona Cancer Center
March 28, 2024
Porphyria: New Therapies and Research
Rebecca Karp, MD
Massachusetts General Hospital
Amy Dickey, MD, MSc
Massachusetts General Hospital
April 4, 2024
DEI as a Competitive Advantage
Clifton David Fuller, MD, PhD
MD Anderson Cancer Center
April 11, 2024
Catch Me If You Can: Resistance to CART Immunotherapy
Marco Ruella, MD
University of Pennsylvania
April 25, 2024
Treating AML in 2024: Individualizing Treatment Approaches with Novel Therapies
Courtney DiNardo, MD, MSCE
MD Anderson Cancer Center
May 2, 2024
ACS-IRG Scholars
Shadi Abdar Esfahani, MD, MPH
Massachusetts General Hospital
Jamie Jacobs, PhD
Massachusetts General Hospital
Julie Miller, MD, PhD
Mass General Cancer Center
Gary X. Wang, MD, PhD
Massachusetts General Hospital
May 9, 2024
Circulating tumor DNA analysis for non-invasive detection of cancers
Max Diehn, MD, PhD
Stanford University
May 16, 2024
State of Cancer: National Efforts to Ensure Health Equity For All Americans
Elizabeth Jaffee, MD
Johns Hopkins Medicine
May 23, 2024
Clinical Pathologic Conference: NEJM Case Records of the MGH: A 59-year-old woman with a breast mass
Bayan Alzumaili, MD; Rebecca Kwait, MD; Daniel Soto, MD; Sahar Shahamatdar, MD, PhD; Janice Thai, MD; Seth Wander, MD, PhD; Lori Wirth, MD
Massachusetts General Hospital
Fall 2023
September 7, 2023
The Chabner Pioneers in Oncology Lectureship – Precision Medicine for Primary and Metastatic Brain Tumors: From Bench to Bedside (and Back to Bench)
Priscilla Brastianos, MD
Mass General Cancer Center
September 21, 2023
Junior Scientist Lectures
Targeted Approaches to Treatment of Pleural Mesothelioma: Are We There Yet?
Ibiayi Dagogo-Jack, MD
Mass General Cancer Center
Gut Bacteria Illuminate a Mechanistic Strategy for Cancer Immunotherapy
Francesca Gazzaniga, PhD
Massachusetts General Hospital
September 28, 2023
Structure and Function of Mammalian SWI/SNF Chromatin Remodeling Complexes in Cancer
Cigall Kadoch, PhD
Dana-Farber Cancer Institute
October 5, 2023
Novel Therapeutics in Gynecologic Cancers
Roisin O’Cearbhaill, MD
Memorial Sloan-Kettering Cancer Center
October 12, 2023
Women in Cancer: Navigating the Glass Ceiling
Lisa Butterfield, PhD
University of California San Francisco
Kornelia Polyak, MD, PhD
Dana-Farber Cancer Institute
Noopur Raje, MD
Mass General Cancer Center
October 26, 2023
Lippard Lecture: Defining and Exploiting Tumor-Host Interactions
Christina Curtis, PhD, MSc
Stanford University
November 9, 2023
Achieving Success as A Square Peg in the Round Hole of Academic Medicine
Jennifer Temel, MD
Mass General Cancer Center
November 30, 2023
Female Participant Engagement in Cancer Research: Sample Programs from the Field to a Pandemic
Lourdes Baezconde-Garbanati, PhD
University of Southern California
December 7, 2023
The Dobbs Decision: Implications for Women’s Health and Cancer Care
Lisa Barroilhet, MD
University of Wisconsin School of Medicine and Public Health
December 14, 2023
Targeted Therapy for Premenopausal Early Breast Cancer: A 100 Year Old Strategy
Sandra Swain, MD
Georgetown University Medical Center
Oncology Advances in Motion
Advances in Motion provides health care professionals with information about the latest breakthroughs, research & clinical advances from Mass General.
Krantz Family Center for Cancer Research
The scientific engine for discovery for the Mass General Cancer Center.
Grand Rounds
Mass General Cancer Center Grand Rounds is a CME accredited weekly seminar series. Cutting edge topics, case studies and conference highlights will be presented.